SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000920465-18-000048
Filing Date
2018-10-24
Accepted
2018-10-24 16:01:27
Documents
39
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ljpc-2018q3document.htm 10-Q 424905
2 EXHIBIT 31.1 exhibit311fy2018q3document.htm EX-31.1 14744
3 EXHIBIT 31.2 exhibit312fy2018q3document.htm EX-31.2 14679
4 EXHIBIT 32.1 exhibit321fy2018q3document.htm EX-32.1 12325
  Complete submission text file 0000920465-18-000048.txt   2171905

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20180930.xml EX-101.INS 259098
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20180930.xsd EX-101.SCH 21326
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20180930_cal.xml EX-101.CAL 40522
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20180930_def.xml EX-101.DEF 99112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20180930_lab.xml EX-101.LAB 321101
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20180930_pre.xml EX-101.PRE 172816
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36282 | Film No.: 181136420
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences